JULIA JENNINGS: Open Payments
NPI 1801168687 · SALINA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$470 in 25 payments from 10 companies in 2025. Trend: 2023 $601 · 2024 $510 · 2025 $470
Food & beverage: $470
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 8 | $151 |
| Merck Sharp & Dohme LLC | 7 | $139 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| E.R. Squibb & Sons, L.L.C. | 2 | $32 |
| Abbott Laboratories | 1 | $23 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| Boston Scientific Corporation | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| SCPHARMACEUTICALS INC. | 1 | $16 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $9 |
Products named: LEQVIO, VERQUVO, CARDIOMEMS, Kerendia, WATCHMAN FLX, JARDIANCE, CAMZYOS, FUROSCIX.
Industry payments across KS — which companies pay providers there.
